← FDA DRUG APPROVALS

FDA ANDA · ANDA075986

TRAMADOL HYDROCHLORIDE

Sponsor: MYLAN

APPLICATION
ANDA075986
TYPE
ANDA
ORIGINAL APPROVAL
2002-06-21
LATEST ACTION
2018-09-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

TRAMADOL HYDROCHLORIDEDiscontinued
TRAMADOL HYDROCHLORIDE 50MG · TABLET · ORAL

Approval history

2018-09-18REMS · Supplement 18AP
2015-11-09Labeling · Supplement 13 · standardAP
2014-10-28Manufacturing (CMC) · Supplement 12AP
2011-03-14Labeling · Supplement 11AP
2004-07-28Labeling · Supplement 3AP
2003-06-03Labeling · Supplement 1AP
2002-06-21OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →